Navigation Links
Purdue Pharma L.P. to Present Data From Clinical Program for Butrans™ (buprenorphine) Transdermal System CIII at PAINWeek® 2010
Date:9/9/2010

for submitting assessments of the REMS.  This information will be available at www.butransrems.com.

About Purdue Pharma L.P.Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue Pharma is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.

Contact:

Shirley Johnson203-588-7681
'/>"/>

SOURCE Purdue Pharma L.P.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Purdue Pharma L.P. Provides Free Security Mobiles and Educational Safety Videos to Good Neighbor Pharmacy Members
2. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
3. New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting
4. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
5. Meditrina Pharmaceuticals, Inc. Announces Allowance of Patent for Treatment of Endometriosis
6. Trubion Pharmaceuticals Announces Early Termination of HSR Waiting Period
7. Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts
8. Access Pharmaceuticals to Present At Rodman & Renshaw Annual Global Investment Conference in New York City
9. Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence
10. Pharmacists May Help Patients Prevent and Detect Heart Disease
11. N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Research and Markets ... "Stability Testing of Pharmaceuticals (London, UK - December ... By attending this comprehensive two day seminar delegates will: ... studies that are suitable for global arketing - ... manage stability samples and facilities - Know how ...
(Date:9/4/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... therapies, today announced its financial results for the fiscal ... of recent Company highlights and expected near-term milestones. ... update conference call and live webcast for investors, analysts ...
(Date:9/3/2015)... Sept. 3, 2015  Cipla, a global pharmaceutical company ... needs of all patients, today announced that its UK ... acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan ... conditions, is valued at $550 million and will be ... transactions is over $200 million for the year ended ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... Sanare, LLC, a leading provider of care ... new consumer brand, BrightSky, have become National Strategic ... (Logo: http://photos.prnewswire.com/prnh/20110414/FL83264LOGO) The sponsorship makes Sanare ... Association,s newly diagnosed patient initiative called "Living With ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association 2
(Date:9/4/2015)... CO (PRWEB) , ... September 04, 2015 , ... Mile ... the ways in which a lack of funding for sidewalks, bike paths, and other ... the report, while the Denver region spends billions of dollars to expand public transit, ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... surrounding communities, is launching a charity effort to provide for the family of ... as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – the ...
(Date:9/4/2015)... Dallas, Texas (PRWEB) , ... September 04, 2015 ... ... the recipient of three separate “Partner of the Year” awards at this year’s ... included being named Microsoft’s 2015 “Partner of the Year” Award Winner for Data ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy SEAL who was ... Ironman World Championships in Kona on October 10th. , Mike is running the race ... through combat and the cutting-edge treatments that restore their quality of life. ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... age for screening, which U.S. is pondering, , TUESDAY, July ... support a growing movement to raise the age at which ... , In England, the recommended age at which a woman ... to 25. In the United States, however, women are told ...
... the target for genistein, a dietary compound, in prostate cancer ... in the Journal of the National Cancer Institute . ... of the Department of Medicine at Northwestern University in Chicago, ... cells by assessing cell invasion and gene and protein expression ...
... , , LAS VEGAS, July 28 ... today announced that it will release its Fiscal 2009 third quarter financial results ... invites you to participate in a teleconference to review the financial ... will be held Tuesday, August 4, 2009 at 1:30 p.m. PDT. To access ...
... NEW YORK, July 28 Finding time to treat the "you" in ... Here,s more on a how you can do just that with ... report from Kellogg,s at: , http://inr.mediaseed.tv/oneClip_C/?feed=LRP2yXtJhkA_O5oRbn5PG4L4KgGq7sMi ... text, graphics and photos for free and unrestricted use at ...
... , , , ... Eleven innovative veterinary students from around the ... of companion animals and wildlife. The students, whose projects were ... program, presented posters of their results at MAF,s annual meeting ...
... 28 Hanger Orthopedic Group, Inc. (NYSE: HGR ) ... 30, 2009, an increase of $12.3 million, or 6.8%, from $181.2 ... or 25.4%, to $10.0 million in the second quarter of 2009 ... quarter of 2009 were $0.31 per diluted share compared to pro ...
Cached Medicine News:Health News:Teens May Not Benefit from Pap Tests 2Health News:Teens May Not Benefit from Pap Tests 3Health News:American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 2Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 2Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 3Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 4Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 2Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 3Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 4Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 5Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 6Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 7Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 8Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 9
1.7% Tryptone, 0.3% Soytone, 0.5% Sodium Chloride, 0.25% Dextrose, 0.25% Potassium Phosphate....
Penicillin G (1 x 10 4 units/mL and Streptomycin (10mg/mL) Solution. 100X Concentrate....
Penicillin-Streptomycin-Glutamine (100X) liquid...
Contains 10,000 units of penicillin (base), 10,000 g of streptomycin (base), and 25 g of amphotericin B/ml utilizing penicillin G (sodium salt), streptomycin sulfate, and amphotericin B as Fungizone ...
Medicine Products: